MktsMarkets

Tyra Biosciences, Inc.
NASDAQ: TYRAKey statistics
TYRA News
Stories mentioning TYRA from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | ||||||||
| Cost of Goods Sold | ||||||||
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | ||||||||
| Research & Development | 33,470 | 28,186 | 25,469 | 24,309 | 24,964 | 22,180 | 22,697 | 17,997 |
| Sales General & Admin | ||||||||
| Total Operating Expenses | 41,998 | 36,516 | 32,944 | 31,452 | 31,850 | 29,719 | 28,604 | 23,532 |
| Operating Income (Loss) | (41,998) | (36,516) | (32,944) | (31,452) | (31,850) | (29,719) | (28,604) | (23,532) |
| Interest Income | ||||||||
| Interest Expense | ||||||||
| Other Expense | ||||||||
| Pretax Income | ||||||||
| Tax Provision | ||||||||
| Net Income (Loss) | (39,305) | (33,834) | (29,868) | (28,098) | (28,147) | (25,571) | (24,016) | (18,702) |
| Earnings Per Share (Basic) | (0.64) | (0.57) | (0.50) | (0.47) | (0.47) | (0.45) | (0.41) | (0.32) |
| Earnings Per Share (Diluted) | (0.64) | (0.57) | (0.50) | (0.47) | (0.47) | (0.45) | (0.41) | (0.32) |
| Weighted Average Shares Outstanding (Basic) | 61,746 | 59,602 | 59,671 | 59,551 | 59,337 | 57,218 | 58,874 | 58,669 |
| Weighted Average Shares Outstanding (Diluted) | 61,746 | 59,602 | 59,671 | 59,551 | 59,337 | 57,218 | 58,874 | 58,669 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About TYRA
Tyra Biosciences, Inc. (NASDAQ: TYRA) is a stock listed on the Nasdaq Stock Market under the ticker symbol TYRA. It last traded at $20.91 (Nov 10, 2026, 9:30 AM ET), down 6.3% on the day. That gives Tyra Biosciences a market capitalisation of $1.5B.
Over the past 52 weeks TYRA has traded between $13.83 and $40.65.
For the quarter ended Mar 31, 2026 it reported a net loss of $39.3M.
| Quarter ended | Revenue | Net income |
|---|---|---|
| Mar 31, 2026 | — | -$39.3M |
| Dec 31, 2025 | — | -$33.8M |
| Sep 30, 2025 | — | -$29.9M |
| Jun 30, 2025 | — | -$28.1M |
From Tyra Biosciences’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…